J. Safra Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$259K Buy
516
+80
+18% +$38.4K 0.01% 212
2026
Q1
$214K Buy
436
+31
+8% +$16.8K 0.01% 213
2025
Q4
$235K Buy
405
+220
+119% +$124K 0.01% 206
2025
Q3
$89.7K Sell
185
-152
-45% -$70.8K 0.01% 199
2025
Q2
$137K Sell
337
-109
-24% -$45.6K 0.01% 173
2025
Q1
$222K Buy
446
+153
+52% +$82.9K 0.02% 135
2024
Q4
$152K Buy
293
+1
+0.3% +$550 0.01% 143
2024
Q3
$179K Buy
292
+2
+0.7% +$1.18K 0.02% 83
2024
Q2
$160K Hold
290
– – 0.02% 69
2024
Q1
$169K Hold
290
– – 0.02% 50
2023
Q4
$154K Hold
290
– – 0.02% 49
2023
Q3
$147K Hold
290
– – 0.02% 52
2023
Q2
$151K Hold
290
– – 0.02% 59
2023
Q1
$167K Buy
+290
New +$163K 0.03% 54
2022
Q3
– Hold
0
– – – 30
2022
Q2
– Hold
0
– – – 37
2022
Q1
– Hold
0
– – – 43

Other funds holding TMO

J. Safra Asset Management's TMO Position: Q2 2026 in Review

J. Safra Asset Management increased its Thermo Fisher Scientific (TMO) stake by 18% in Q2 2026, buying an estimated $38.4K and bringing the position to 516 shares worth $259K. The position accounts for 0.01% of the portfolio, ranked #212.

J. Safra Asset Management first reported a position in TMO in Q1 2023 and has held it in 14 quarters since. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • J. Safra Asset Management held 516 shares of Thermo Fisher Scientific worth $259K as of Q2 2026.
  • J. Safra Asset Management bought 80 Thermo Fisher Scientific shares in Q2 2026, an estimated $38.4K.
  • Thermo Fisher Scientific made up 0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #212 holding.
  • J. Safra Asset Management first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 14 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.